Assenagon Asset Management S.A. Sells 11,454 Shares of Humana Inc. $HUM

Assenagon Asset Management S.A. lowered its stake in shares of Humana Inc. (NYSE:HUMFree Report) by 62.9% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 6,758 shares of the insurance provider’s stock after selling 11,454 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Humana were worth $1,172,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the stock. Montag A & Associates Inc. grew its position in shares of Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after acquiring an additional 94 shares during the period. CoreCap Advisors LLC raised its holdings in shares of Humana by 54.4% in the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 37 shares during the period. Fideuram Asset Management Ireland dac purchased a new position in Humana in the fourth quarter valued at approximately $27,000. Reflection Asset Management purchased a new position in Humana in the fourth quarter valued at approximately $29,000. Finally, Rosenberg Matthew Hamilton grew its holdings in Humana by 136.0% during the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 68 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

Several analysts have issued reports on HUM shares. Seaport Research Partners lowered Humana to a “neutral” rating in a research note on Wednesday, May 20th. Evercore lifted their price objective on Humana from $250.00 to $370.00 in a report on Thursday, June 11th. Zacks Research upgraded Humana from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 13th. Needham & Company LLC initiated coverage on shares of Humana in a report on Wednesday, May 20th. They set a “buy” rating on the stock. Finally, Jefferies Financial Group upgraded shares of Humana from a “buy” rating to a “buy” rating in a research report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, sixteen have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, Humana currently has an average rating of “Hold” and an average target price of $293.09.

Get Our Latest Stock Analysis on Humana

Humana Stock Up 3.2%

HUM stock opened at $409.92 on Thursday. The stock has a 50-day simple moving average of $314.71 and a two-hundred day simple moving average of $248.64. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $414.82. The firm has a market capitalization of $49.22 billion, a PE ratio of 43.84, a PEG ratio of 2.26 and a beta of 0.71. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66.

Humana (NYSE:HUMGet Free Report) last announced its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The firm had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. During the same period in the prior year, the firm posted $11.58 earnings per share. The company’s revenue for the quarter was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. On average, equities analysts predict that Humana Inc. will post 9.04 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.885 dividend. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a yield of 0.9%. Humana’s dividend payout ratio is currently 37.86%.

Humana Profile

(Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Featured Articles

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.